Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
News: Latest News
Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
All NewsEconomyCurrencies & ForexEconomic EventsCryptocurrenciesCybersecurityPress Releases

Namibia to start destroying expired vaccines due to slow uptake

11/25/2021 | 07:25am EST
Picture illustration of vials with Pfizer-BioNTech and AstraZeneca coronavirus disease (COVID-19) vaccine labels

WINDHOEK (Reuters) - Namibia has warned that more than 268,000 doses of AstraZeneca and Pfizer COVID-19 vaccines are at risk of being destroyed, some as early as next week, due to a slow uptake by citizens.

Ben Nangombe, executive director in the health ministry, told Reuters on Thursday that 52,261 AstraZeneca vaccines will expire on Tuesday next week, while 215,996 Pfizer shots will be destroyed in January and February if they find no takers as vaccine hesitancy rises.

Namibia, which has started vaccinating 12- to 17-year olds with the Pfizer vaccine after the WHO said on Nov. 15 that it is suitable for people in that age group, has 809,414 doses available nationally.

The southern African nation recorded 15 new cases on Tuesday to bring the number of active cases to 85 compared to a peak of 2,547 cases in a single day on June 24.

Only 298,503, or 20% of an estimated eligible population of 1.5 million, have been fully vaccinated in Namibia, with the Chinese-made Sinopharm vaccine the most used after 145,483 people received two doses since the country's vaccination programme started in March.

The Russian-made Sputnik V vaccine has been used the least, with only 71 people fully vaccinated before its rollout was suspended on Oct. 23, days after the drugs regulator in neighbouring South Africa flagged concerns about its safety for people at risk of HIV.

South African health regulator SAHPRA decided against approving an emergency use application for Sputnik V after some studies suggested vaccines using the Adenovirus Type 5 vector - which Sputnik V does - can lead to higher susceptibility to HIV in men.

South Africa and Namibia have high HIV prevalence rates.

(Reporting by Nyasha Nyaungwa; editing by Wendell Roelf and Giles Elgood)

By Nyasha Nyaungwa


ę Reuters 2021
Latest news "Economy & Forex"
05:55pBitcoin Lost 2.95% to $41740.57 at 5 p.m. ET -- Data Talk
DJ
05:55pEthereum Lost 4.88% to $3168.54 at 5 p.m. ET -- Data Talk
DJ
05:55pDogecoin Lost 5.71% to $0.167at 5 p.m. ET -- Data Talk
DJ
05:55pActivision fires dozens over misconduct -report
RE
05:48pDollar Gains 0.37% to 114.62 Yen -- Data Talk
DJ
05:48pSterling Lost 0.23% to $1.3646 -- Data Talk
DJ
05:48pThe WSJ Dollar Index Rises 0.09% to 89.26 -- Data Talk
DJ
05:48pEuro Lost 0.07% to $1.1408 -- Data Talk
DJ
05:32pToronto market notches 8-week high as energy shares climb
RE
05:14pActivision Blizzard fires more people in sexual harassment probe
RE
Latest news "Economy & Forex"